A swallowable tablet containing 80-95 % N-acetylcysteine by weight, 0.5-4 % by weight with respect to N-acetylcysteine of a binder and further pharmaceutically acceptable excipients, such as diluents, disintegrants, lubricants, optionally in the presence of a flowing agent and of a film-...
The aim of the study was to evaluate the efficacy and safety of Cystone forte tablet in urolithiasis. A randomized, open-label, comparative clinical study was conducted in sixty-two subjects presenting with urolithiasis as diagnosed clinically with calculi measuring 5 to 12mm in size and subjects ...
The patients were advised to take Cystone or placebo in a dose of one tablet, thrice daily for 6 months. Patients kept a record of number of pain episodes; severity of pain was assessed by Visual Analogue Scale (VAS). In addition, other parameters such as fever, low backache and ...